Cutaneous T-Cell Lymphoma Recurrent Active Not Recruiting Phase 2 Trials for Sirolimus (DB00877)

Also known as: T-Cell Lymphoma Relapsed / Recurrent T-Cell Lymphoma / Recurrent Cutaneous T-cell lymphoma / T-cell lymphoma recurrent / Relapsed T-Cell Lymphoma / T-cell lymphoma NOS recurrent

IndicationStatusPhase
DBCOND0136063 (Cutaneous T-Cell Lymphoma Recurrent)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02722668UCB Transplant for Hematological Diseases Using a Non Myeloablative PrepTreatment